Lankenau Medical Center, Wynnewood, PA, USA.
Lankenau Institute for Medical Research, Wynnewood, PA, USA.
J Appl Clin Med Phys. 2020 Mar;21(3):45-51. doi: 10.1002/acm2.12818. Epub 2020 Feb 11.
Prescription practice in SRS plans for brain tumors differs significantly for different modalities. In this retrospective study, the strategies to optimize SRS plans for brain tumors with volumetric arc therapy (VMAT) were presented.
Fifty clinically treated cases were stratified by the maximum target size into two groups (≥ 2 cm in 25 cases and <2 cm but ≥1 cm in 25 cases), which were optimized using traditional LINAC MLC-based approaches with the average prescription isodose line (P-IDL) of (91.4 ± 0.6)%. Four to five plans have been created for each case with variation of the P-IDL from 65% to 90%. The optimization strategies to select an optimal P-IDL, to use tuning structures within the target and beyond as well as to use NTO (normal tissue objectives), were applied to all new plans.
The optimal P-IDL was found to be around 75%. After applying the new optimization strategies with an average P-IDL of 74.8%, the mean modified gradient index (mGI) and V12 were reduced by 25% and 35%, respectively for both groups. The Paddick conformity index (PCI) was averagely improved by 8%. The average homogeneity index (HI) and focal index (FI) were increased by 22% and 50%, respectively. The mGI was inversely proportional to the PTV volumes. The shape of the dose distribution in target was also changed from concave to convex. The comparison of PCI with historical data from other institutes and modalities shows that the plans in this study have the best conformity near the target.
With the new optimization strategies for VMAT SRS plan of brain tumor more conformal plans in both high and intermediate dose region (~50% of the PD) were created, in which the dose in the core of the target was notably increased while V12 and mGI were significantly decreased, and PCI was improved. The mGI was inversely proportional to the PTV volumes. The optimal P-IDL is around 75%. The average PCI is the best in this study compared with the published historical data. These strategies are applicable to treatment planning for multiple brain and liver tumors where sparing the tissue peripheral to the target is critical.
立体定向放射手术(SRS)计划中的处方实践因不同模式而有很大差异。在这项回顾性研究中,介绍了使用容积弧形治疗(VMAT)优化脑肿瘤 SRS 计划的策略。
将 50 例临床治疗的病例按最大靶区大小分为两组(≥2cm 25 例,<2cm 但≥1cm 25 例),分别采用平均处方等剂量线(P-IDL)为(91.4±0.6)%的传统 LINAC MLC 方法进行优化。为每个病例创建了 4 到 5 个计划,P-IDL 从 65%到 90%不等。将选择最佳 P-IDL、在靶区和靶区外使用调强结构以及使用 NTO(正常组织目标)的优化策略应用于所有新计划。
发现最佳 P-IDL 约为 75%。应用平均 P-IDL 为 74.8%的新优化策略后,两组的平均修正梯度指数(mGI)和 V12 分别降低了 25%和 35%。Paddick 适形指数(PCI)平均提高了 8%。平均均匀性指数(HI)和聚焦指数(FI)分别增加了 22%和 50%。mGI 与 PTV 体积成反比。靶区的剂量分布形状也从凹变凸。与其他机构和模式的历史数据相比,PCI 的比较表明,本研究中的计划在靶区附近具有最佳的适形性。
使用新的 VMAT SRS 计划脑肿瘤优化策略,在高剂量和中剂量区(约 50%PD)创建了更适形的计划,其中靶区核心的剂量明显增加,同时 V12 和 mGI 显著降低,PCI 得到改善。mGI 与 PTV 体积成反比。最佳 P-IDL 约为 75%。与已发表的历史数据相比,本研究中的平均 PCI 最佳。这些策略适用于需要保护靶区周围组织的多脑和肝脏肿瘤的治疗计划。